Barclays downgrades Array Technologies on weak growth outlook, margin strain
Go back to Barclays downgrades Array Technologies on weak growth outlook, margin strain| Array Biopharma, Inc. (NASDAQ: ARRY) | Delayed: 3.37 +0.04 (1.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.33 | 52 Week High | $7.27 | |||
| Open | $3.40 | 52 Week Low | $2.39 | |||
| Day High | $3.47 | P/E | N/A | |||
| Day Low | $3.37 | EPS | $-0.61 | |||
| Volume | 3,681,104 | |||||
| NYSE Arca Tech 100 ETF (NASDAQ: NXT) | Delayed: 80.77 +1.74 (2.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.03 | 52 Week High | $25.39 | |||
| Open | $81.12 | 52 Week Low | $13.13 | |||
| Day High | $82.27 | P/E | N/A | |||
| Day Low | $80.44 | EPS | $0.00 | |||
| Volume | 922,288 | |||||



